Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71% Market Closed
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Kanion Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Interest Income Expense
ÂĄ53.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
ÂĄ1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
ÂĄ149.9m
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
ÂĄ538m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
26%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
ÂĄ1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-7%
CAGR 10-Years
37%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Interest Income Expense
-ÂĄ20.1m
CAGR 3-Years
-107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
53.1m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Interest Income Expense amounts to 53.1m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
210%

Over the last year, the Interest Income Expense growth was 210%.

Back to Top